| [1] |
Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients [J]. Kidney Int, 2006, 70(4): 771-780.
|
| [2] |
Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study [J]. Clin J Am Soc Nephro, 2015, 10(1): 98-109.
|
| [3] |
Susantitaphong P, Vadcharavivad S, Susomboon T, et al. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism [J]. Ren Fail, 2019, 41(1): 326-333.
|
| [4] |
Fukagawa M, Yokoyama K, Shigematsu T, et al. A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients [J]. Nephrol Dial Transpl, 2017, 32(10): 1723-1730.
|
| [5] |
Giordano A, Rubello D, Casara D. New trends in parathyroid scintigraphy [J]. Eur J Nucl Med, 2001, 28(9): 1409-1420.
|
| [6] |
Fraser WD. Hyperparathyroidism [J]. Lancet, 2009, 374(9684): 145-158.
|
| [7] |
Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease [J]. Kidney Int, 2007, 71(1): 31-38.
|
| [8] |
Mizobuchi M, Ogata H, Koiwa F. Secondary hyperparathyroidism: pathogenesis and latest treatment [J]. Ther Apher Dial, 2019, 23(4): 309-318.
|
| [9] |
Tominaga Y, Sato K, Tanaka Y, et al. Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure [J]. Clin Nephrol, 1995, 44(Suppl 1): S42-S47.
|
| [10] |
Roth SI, Marshall RB. Pathology and ultrastructure of the human parathyroid glands in chronic renal failure [J]. Arch Intern Med, 1969, 124(4): 397-407.
|
| [11] |
Schneider R, Slater EP, Karakas E, et al. Initial parathyroid surgery in 606 patients with renal hyperparathyroidism [J]. World J Surg, 2012, 36(2): 318-326.
|
| [12] |
Moe SM, Chertow GM, Coburn JW, et al. Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl [J]. Kidney Int, 2005, 67(2): 760-771.
|
| [13] |
Madorin C, Owen RP, Fraser WD, et al. The surgical management of renal hyperparathyroidism [J]. Eur Arch Otorhinolaryngol, 2012, 269(6): 1565-1576.
|
| [14] |
Schneider R, Bartsch DK. Role of surgery in the treatment of renal secondary hyperparathyroidism [J]. Brit J Surg, 2015, 102(4): 289-290.
|
| [15] |
Chen J, Jia X, Kong X, et al. Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: a systematic review and meta-analysis [J]. Nephrology (Carlton), 2017, 22(5): 388-396.
|
| [16] |
Anderson K, Ruel E, Adam MA, et al. Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes [J]. Am J Surg, 2017, 214(5): 914-919.
|
| [17] |
Tominaga Y, Kakuta T, Yasunaga C, et al. Evaluation of parathyroidectomy for secondary and tertiary hyperparathyroidism by the Parathyroid Surgeons' Society of Japan [J]. Ther Apher Dial, 2016, 20(1): 6-11.
|
| [18] |
Strambu V, Bratucu M, Garofil D, et al. The value of imaging of the parathyroid glands in secondary hyperparathyroidism [J]. Chirurgia (Bucur), 2019, 114(5): 541-549.
|
| [19] |
Coakley AJ, Kettle AG, Wells CP, et al. 99Tcm sestamibi--a new agent for parathyroid imaging [J]. Nucl Med Commun, 1989, 10(11): 791-794.
|
| [20] |
Mitchell BK, Kinder BK, Merrell RC. Localization studies in patients with hyperparathyroidism [J]. Surg Clin North Am, 1995, 75(3): 483-498.
|
| [21] |
Greenspan BS, Dillehay G, Intenzo C, et al. SNM practice guideline for parathyroid scintigraphy 4.0 [J]. J Nucl Med Technol, 2012, 40(2): 111-118.
|
| [22] |
Jiang S, Yang T, Zou Q, et al. The role of 99mTc-MIBI SPECT/CT in patients with secondary hyperparathyroidism: comparison with 99mTc-MIBI planar scintigraphy and ultrasonography [J]. BMC Med Imaging, 2020, 20(1): 115.
|
| [23] |
Pham TH, Sterioff S, Mullan BP, et al. Sensitivity and utility of parathyroid scintigraphy in patients with primary versus secondary and tertiary hyperparathyroidism [J]. World J Surg, 2006, 30(3): 327-332.
|
| [24] |
Marmin C, Toledano M, Lemaire S, et al. Computed tomography of the parathyroids: the value of density measurements to distinguish between parathyroid adenomas of the lymph nodes and the thyroid parenchyma [J]. Diagn Interv Imaging, 2012, 93(7-8): 597-603.
|
| [25] |
Liu M, Qiu N, Zha S, et al. To assess the effects of parathyroidectomy (TPTX versus TPTX+AT) for secondary hyperparathyroidism in chronic renal failure: a systematic review and meta-analysis [J]. Int J Surg, 2017, 44: 353-362.
|
| [26] |
Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism [J]. Clin J Am Soc Nephrol, 2018, 13(6): 952-961.
|
| [27] |
Yuan F, Yu W, Waqas A, et al. Radioactive probe-guided parathyroidectomy for secondary hyperparathyroidism [J]. Chin Med J (Engl), 2014, 127(13): 2413-2418.
|
| [28] |
Schneider R, Ramaswamy A, Slater EP, et al. Cryopreservation of parathyroid tissue after parathyroid surgery for renal hyperparathyroidism: does it really make sense? [J]. World J Surg, 2012, 36(11): 2598-2604.
|
| [29] |
Chen H, Wang TS, Yen TWF, et al. Operative failures after parathyroidectomy for hyperparathyroidism [J]. Ann Surg, 2010, 252(4): 691-695.
|
| [30] |
Kose E, Rudin AV, Kahramangil B, et al. Autofluorescence imaging of parathyroid glands: an assessment of potential indications [J]. Surgery, 2020, 167(1): 173-179.
|
| [31] |
Cui L, Gao Y, Yu H, et al. Intraoperative parathyroid localization with near-infrared fluorescence imaging using indocyanine green during total parathyroidectomy for secondary hyperparathyroidism [J]. Sci Rep, 2017, 7(1): 8193.
|
| [32] |
Gasparri G, Camandona M, Abbona GC, et al. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies [J]. Ann Surg, 2001, 233(1): 65-69.
|
| [33] |
Tominaga Y, Numano M, Tanaka Y, et al. Surgical treatment of renal hyperparathyroidism [J]. Semin Surg Oncol, 1997, 13(2): 87-96.
|
| [34] |
Neyer U, Hoerandner H, Haid A, et al. Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection [J]. Nephrol Dial Transpl, 2002, 17(4): 625-629.
|
| [35] |
Pattou FN, Pellissier LC, Noёl C, et al. Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism [J]. World J Surg, 2000, 24(11): 1330-1334.
|
| [36] |
Schneider R, Waldmann J, Ramaswamy A, et al. Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy [J]. World J Surg, 2011, 35(6): 1260-1265.
|
| [37] |
Zhang L, Xing C, Shen C, et al. Diagnostic accuracy study of intraoperative and perioperative serum intact PTH level for successful parathyroidectomy in 501 secondary hyperparathyroidism patients [J]. Sci Rep, 2016, 6: 26841.
|
| [38] |
Moor JW, Roberts S, Atkin SL, et al. Intraoperative parathyroid hormone monitoring to determine long-term success of total parathyroidectomy for secondary hyperparathyroidism [J]. Head Neck, 2011, 33(3): 293-296.
|
| [39] |
Barczyński M, Cichoń S, Konturek A, et al. A randomised study on a new cost-effective algorithm of quick intraoperative intact parathyroid hormone assay in secondary hyperparathyroidism [J]. Langenbecks Arch Surg, 2005, 390(2): 121-127.
|
| [40] |
Lorenz K, Ukkat J, Sekulla C, et al. Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol [J]. World J Surg, 2006, 30(5): 743-751.
|